Infection control in the ICU

Chest

Volumn 120, Issue 6, 2001, Pages 2059-2093

  Eggimann, Philippe ^a   Pittet, Didier ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Bloodstream infection; Critical care; Epidemiology; Nosocomial infection; Prevention; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

ABDOMINAL INFECTION; ARTIFICIAL VENTILATION; BACTEREMIA; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG CONTROL; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INJURY; INTENSIVE CARE; LOWER RESPIRATORY TRACT INFECTION; PATHOPHYSIOLOGY; PATIENT CARE; PNEUMONIA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINUSITIS; SURGICAL INFECTION; URINARY TRACT INFECTION; WASTE MANAGEMENT;

EID: 0035680987     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.6.2059     Document Type: Article

References (398)

1. Incidence of adverse events and negligence in hospitalized patients: Results of the Harvard Medical Practice Study I
2. The nature of adverse events in hospitalized patients: Results of the Harvard Medical Practice Study II
3. Relation between malpractice claims and adverse events due to negligence: Results of the Harvard Medical Practice Study III
4. Incidence and types of adverse events and negligent care in Utah and Colorado
5. Institute of Medicine medical error figures are not exaggerated
6. Safe health care: Are we up to it?
7. Deaths due to medical errors are exaggerated in Institute of Medicine report
8. The Institute of Medicine report on medical errors: Could it do harm?
9. An alternative strategy for studying adverse events in medical care
10. Medication errors in paediatric practice: Insights from a continuous quality improvement approach
11. Patient risk factors for adverse drug events in hospitalized patients: ADE Prevention Study Group
12. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit
13. Pathway to the present: A personal view of critical care
14. Public health focus: Surveillance, prevention, and control of nosocomial infections
15. The prevalence of nosocomial infection in intensive care units in Europe: Results of the European Prevalence of Infection in Intensive Care (EPIC) Study
16. Prevalence and risk factors for nosocomial infections in four university hospitals in Switzerland
17. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals
18. Infection control and hospital epidemiology outside the United States
19. Risk factors for ICU-acquired pneumonia
20. The prevention of ventilator-associated pneumonia
21. Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients
22. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients
23. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care
24. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene
25. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: A randomized trial
26. CDC definitions for nosocomial infections
27. Consensus paper on the surveillance of surgical wound infections
28. Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: Role of a hospital information system
29. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus
30. Nosocomial infections in Swiss university hospitals: A multi-center survey and review of the published experience; Swiss-Noso Network
31. Candida colonization and subsequent infections in critically ill surgical patients
32. Principles of applied epidemiology for infection control
33. How to survey nosocomial infections
34. Nosocomial infections in medical intensive care units in the United States: National Nosocomial Infections Surveillance System
35. Evaluation of clinical practice guidelines on outcome of infection in medical intensive care unit patients
36. Nosocomial infections in pediatric intensive care units in the United States: National Nosocomial Infections Surveillance System
37. Nosocomial infections in pediatric patients: A European, multicenter prospective study; European Study Group
38. An analysis of two prevalence surveys of nosocomial infection in German intensive care units
39. Surveillance of nosocomial infections: Prospective study in a pediatric intensive care unit; background, patients and methods
40. Risk factors for nosocomial infections in a critically ill pediatric population: A 25-month prospective cohort study
41. Nosocomial infections: Prospective survey of incidence in five French intensive care units
42. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units
43. Nosocomial infections in critically ill infectious disease patients: Results of a 7-year focal surveillance
44. Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit
45. Scheduled change of antibiotic classes: A strategy to decrease the incidence of ventilator-associated pneumonia
46. Nosocomial infections in an oncology intensive care unit
47. Nosocomial infections in coronary care units in the United States: National Nosocomial Infections Surveillance System
48. Nosocomial infections in a burn intensive care unit
49. Monitoring hospital-acquired infections to promote patient safety: United States, 1990-1999
50. Nosocomial infections in combined medical-surgical intensive care units in the United States
51. Nosocomial infections in the intensive care units at a university hospital in a developing country: Comparison with National Nosocomial Infections Surveillance intensive care unit rates
52. Device-associated, device-day infection rates in an Israeli adult general intensive care unit
53. Nosocomial infections in the surgical intensive care unit: A difference between trauma and surgical patients
54. Nosocomial infections in a neurosurgery intensive care unit
55. Risk factors for nosocomial infection in critically ill children: A prospective cohort study
56. Device-associated nosocomial infection surveillance in neonatal intensive care using specified criteria for neonates
57. Nosocomial infections in pediatric patients with burns
58. Nosocomial infection rates in adult and pediatric intensive care units in the United States: National Nosocomial Infections Surveillance System
59. National Nosocomial Infection Surveillance (NNIS) System report: Data summary from January 1990-May 1999, issued June 1999
60. Meaningful interhospital comparisons of infection rates in intensive care units
61. Impact of ICU nosocomial infections on outcome from surgical care
62. Influence of nosocomial infection on mortality rate in an intensive care unit
63. Risk factors and outcome of nosocomial infections: Results of a matched case-control study of ICU patients
64. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: A matched, risk-adjusted, cohort study
65. Evaluation of outcome of intravenous catheter-related infections in critically ill patients
66. Nosocomial bloodstream infection in the critically ill
67. Excess mortality in critically ill patients with nosocomial bloodstream infections
68. The attributable mortality and costs of primary nosocomial bloodstream infection in the intensive care unit
69. Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: A case-control study of adult burn patients
70. Nosocomial bacteremia in a medical-surgical intensive care unit: Epidemiologic characteristics and factors influencing mortality in 111 episodes
71. Serious infection in the intensive therapy unit: A 15-year study of bacteraemia
72. Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs, and attributable mortality
73. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality
74. Hospital-acquired pneumonia: Attributable mortality and morbidity
75. Nosocomial pneumonia in patients receiving continuous mechanical ventilation: Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques
76. Nosocomial pneumonia and mortality among patients in intensive care units
77. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient: The Canadian Critical Trials Group
78. Mortality associated with nosocomial urinary-tract infection
79. Attributable risk estimation: An open issue
80. Nosocomial infection and fatality in medical and surgical intensive care unit patients
81. Prevalence of infections in intensive care units in Mexico: A multicenter study
82. Severity of illness scoring systems to adjust nosocomial infection rates: A review and commentary
83. A novel score for predicting the mortality of septic shock patients
84. A look into the nature and causes of human errors in the intensive care unit
85. Iatrogenic complications in adult intensive care units: A prospective two-center study
86. Hospital mortality in relation to staff workload: A 4-year study in an adult intensive-care unit
87. The role of understaffing and overcrowding in recurrent outbreaks of staphylococcal infection in a neonatal special-care unit
88. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit
89. The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit
90. Nursing staff workload as a determinant of methicillin-resistant Staphylococcus aureus spread in an adult intensive therapy unit
91. The role of understaffing in central venous catheter-associated bloodstream infections
92. Outbreak of Enterobacter cloacae related to understaffing, overcrowding, and poor hygiene practices
93. Endemic nosocomial transmission of Staphylococcus epidermidis bacteremia isolates in a neonatal intensive care unit over 10 years
94. Streptococcus faecium outbreak in a neonatal intensive care unit
95. Outbreak of Candida tropicalis fungemia in a neonatal intensive care unit
96. An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers’ pet dogs
97. Bacterial colonization of neonates admitted to an intensive care environment
98. National epidemiology of mycoses survey (NEMIS): Variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units
99. Magnitude and prevention of nosocomial infections in the intensive care unit
100. Antimicrobial resistance in intensive care units
101. Antimicrobial use and resistance in eight US hospitals: Complexities of analysis and modeling; Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals
102. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2; Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals
103. Predominant pathogens in hospital infections
104. Does antibiotic restriction prevent resistance?
105. A comparison of clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital
106. Clinical risk factors for methicillin-resistant Staphylococcus aureus bacteriuria in a skilled-care nursing home
107. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital
108. Characteristics of polyclonal endemicity of Pseudomonas aeruginosa colonization in intensive care units. Implications for infection control
109. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries: French and Portuguese ICU Study Groups
110. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance
111. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae
112. To control or not to control colonization with MRSA… That’s the question!
113. Increasing bacteremia due to coagulase-negative staphylococci: Fiction or reality?
114. Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management
115. MRSA: A European currency of infection control
116. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals
117. Compliance with handwashing in a teaching hospital: Infection Control Program
118. Recommendations for preventing the spread of vancomycin resistance: Recommendations of the Hospital Infection Control Practice Advisory Committee (HICPAC)
119. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
120. Emergence of vancomycin resistance in Staphylococcus aureus: Glycopeptide-Intermediate Staphylococcus aureus Working Group
121. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection
122. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital
123. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance
124. Implications of vancomycin-resistant Staphylococcus aureus
125. New resistance in Staphylococcus aureus
126. Interim guidelines for prevention and control of Staphylococcal infections associated with reduced susceptibility to vancomycin
127. Vancomycin-resistant Staphylococcus aureus: Perspectives on measures needed for control
128. Vancomycin-resistant enterococci
129. Risk factors for acquisition of gentamicin-resistant enterococci: A multivariate analysis
130. Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection
131. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients
132. Managing antibiotic resistance
133. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci
134. Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams
135. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli: Study of an outbreak in an intensive care unit
136. Interrepeat fingerprinting of third-generation cephalosporin-resistant Enterobacter cloacae isolated during an outbreak in a neonatal intensive care unit
137. Prospective survey of colonization and infection caused by expanded-spectrum-beta-lactamase-producing members of the family enterobacteriaceae in an intensive care unit
138. Intravascular-catheter-related infections
139. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990: National Nosocomial Infections Surveillance System
140. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989: National Nosocomial Infections Surveillance System
141. Nosocomial bloodstream infections: Secular trends in rates, mortality, and contribution to total hospital deaths
142. Frequency, mortality and risk factors of candidemia at a tertiary care hospital
143. Candida infections in intensive care units
144. The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance
145. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
146. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
147. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia: NIAID Mycoses Study Group and the Candidemia Study Group
148. Prevention of severe Candida spp infections in nonneutropenic, high risk critically ill patients
149. Use of fluconazole is not associated with a higher incidence of Candida krusei and other non-albicans Candida species
150. The epidemiology of hematogenous candidiasis by different Candida species
151. The effect of prophylactic fluconazole on the clinical spectrum of fungal diseases in bone marrow transplant recipients with special attention to hepatic candidiasis: An autopsy study of 355 patients
152. International surveillance of blood stream infections due to Candida species in the European SENTRY program: Species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents; SENTRY Participant Group (Europe)
153. Bloodstream infections due to candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998
154. Infection control and hospital epidemiology outside the United States
155. Nosocomial and community-acquired infections in Germany: Summary of the results of the First National Prevalence Study (NIDEP)
156. The intensive care unit
157. Requirements for infrastructure and essential activities of infection control and epidemiology in hospitals: A consensus panel report; Society for Healthcare Epidemiology of America
158. Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: Role of a hospital information system
159. Viridans streptococcal bacteremias in neutropenic cancer patients: Clinical spectrum and risk factors
160. Unusual cause of lethal pulmonary aspergillosis in patients with chronic obstructive pulmonary disease
161. Epidemiology and control of nosocomial infections in adult intensive care units
162. Guideline for isolation precautions in hospitals: The Hospital Infection Control Practices Advisory Committee
163. Risk reduction in the intensive care unit
164. Society for Healthcare Epidemiology of America, and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: Guidelines for the prevention of antimicrobial resistance in hospitals
165. Translating practice guidelines into patient care: Guidelines at the bedside
166. Reasons for noncompliance with infection control guidelines
167. Control of endemic methicillin-resistant Staphylococcus aureus: A cost-benefit analysis in an intensive care unit
168. Isolation
169. Handwashing: The Semmelweis lesson forgotten?
170. Hand-washing patterns in medical intensive-care units
171. Hand-washing and nosocomial infections
172. Bacterial contamination of the hands of hospital staff during routine patient care
173. APIC guidelines for handwashing and hand antisepsis in health care settings
174. A multicentre survey of hand hygiene practice in intensive care units
175. Handwashing and glove use in a long-term-care facility
176. Availability of an alcohol solution can improve hand disinfection compliance in an intensive care unit
177. Factors influencing handwashing behavior of patient care personnel
178. Nurses’ hand decontamination practice: Results of a local study
179. It is time for action: Improving hand hygiene in hospitals
180. Skin hygiene and infection prevention: More of the same or different approaches?
181. UK handwashing initiative
182. Increasing ICU staff handwashing: Effects of education and group feedback
183. Behavioral interventions to improve infection control practices
184. Improving compliance with hand hygiene in hospitals
185. Failure of bland soap hand-wash to prevent hand transfer of patient bacteria to urethral catheters
186. No time for handwashing? Handwashing versus alcoholic rub; can we afford 100% compliance?
187. A multifaceted approach to changing handwashing behavior
188. Changing physicians’ practices
189. Techniques to improve physicians’ use of diagnostic tests: A new conceptual framework
190. Isolation of patients with communicable diseases
191. Anatomy of a defective barrier: Sequential glove leak detection in a surgical and dental environment
192. Latex gloves not enough to exclude viruses
193. Clostridium difficile contamination of blood pressure cuffs: A call for a closer look at gloving practices in the era of universal precautions
194. An outbreak of gram-negative bloodstream infections in chronic hemodialysis patients
195. Removal of nosocomial pathogens from the contaminated glove: Implications for glove reuse and handwashing
196. Handwashing and use of examination gloves
197. Examination gloves as barriers to hand contamination in clinical practice
198. Why, when and how to isolate patients in the ICU
199. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994
200. Identification of factors that disrupt negative air pressurization of respiratory isolation rooms
201. Respirators, recommendations, and regulations: The controversy surrounding protection of health care workers from tuberculosis
202. The value of protective isolation in preventing nosocomial infections in high risk patients
203. Psychological impact of the management of methicillin-resistant Staphylococcus aureus (MRSA) in patients with spinal cord injury
204. Does isolation of patients with infections induce mental illness?
205. The pros and cons of isolation and containment
206. Toward a more thoughtful approach to fever in critically ill patients
207. SHEA conference on antimicrobial resistance: Society for Healthcare Epidemiology of America
208. Antimicrobial cycling: Lessons learned from the aminoglycoside experience
209. A three-year study of positive blood cultures, with emphasis on prognosis
210. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: A multicenter prospective study in intensive care units; French ICU Group for Severe Sepsis
211. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults
212. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment: Analysis of 189 episodes
213. Nosocomial pneumonia: A multivariate analysis of risk and prognosis
214. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients
215. Influence of antimicrobial treatment on mortality in septicemia
216. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
217. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: A challenge to hospital leadership
218. Practice guidelines for evaluating new fever in critically ill adult patients: Task force of the Society of Critical Care Medicine and the Infectious Diseases Society of America
219. Fever in the ICU
220. Community-acquired pneumonia in adults: Guidelines for management; the Infectious Diseases Society of America
221. Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy; American Thoracic Society Medical Section of the American Lung Association
222. American College of Chest Physicians/Society of Critical Care Medicine consensus conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
223. Antimicrobial therapy of ventilator-associated pneumonia: How to select an appropriate drug regimen
224. A computer-assisted management program for antibiotics and other antiinfective agents
225. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer
226. Impact of immunomodulating therapy on morbidity in patients with severe sepsis
227. Carbapenems: Monotherapy in intra-abdominal sepsis
228. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections
229. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections: The Intra-Abdominal Infection Study Group
230. Towards invasive diagnostic techniques as standard management of ventilator-associated pneumonia
231. Implementing antibiotic practice guidelines through computer-assisted decision support: Clinical and financial outcomes
232. Effects of requiring prior authorization for selected antimicrobials: Expenditures, susceptibilities, and clinical outcomes
233. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance?
234. Nosocomial infection following cardiovascular surgery: Comparison of two periods, 1987 vs 1992
235. Aminoglycoside resistance and aminoglycoside usage: Ten years of experience in one hospital
236. Is “crop rotation” of antibiotics the solution to a “resistant” problem in the ICU?
237. Strategies for study of the role of cycling on antimicrobial use and resistance
238. Rotation and restricted use of antibiotics in a medical intensive care unit: Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria
239. Antibiotic cycling: Is it ready for prime time?
240. Selective decontamination of the digestive tract in critically ill patients
241. The First European Consensus Conference in Intensive Care Medicine: Selective decontamination of the digestive tract in intensive care unit patients
242. Selective decontamination of the digestive tract: An overview
243. Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass: Role of type of flow and protective effect of selective digestive decontamination
244. Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass: Role of type of flow and protective effect of selective digestive decontamination
245. Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia; a randomized, placebo-controlled, double-blind clinical trial
246. A controlled trial in intensive care units of selective decontamination of the digestive tract with nonabsorbable antibiotics: The French Study Group on Selective Decontamination of the Digestive Tract
247. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit
248. Selective decontamination of the digestive tract in multiple trauma patients: A prospective double-blind, randomized, placebo-controlled study
249. Selective decontamination of the digestive tract in surgical patients: A systematic review of the evidence
250. Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit
251. The role of selective digestive tract decontamination on mortality and respiratory tract infections: A meta-analysis
252. Meta-analysis of randomised controlled trials of selective decontamination of the digestive tract
253. Selective decontamination of the digestive tract in intensive care patients
254. Does selective decontamination of the digestive tract reduce mortality for severely ill patients?
255. Selective decontamination of the digestive tract: 13 Years on, what it is and what it is not
256. Selective gut decontamination in intensive care and surgical practice: Where are we?
257. Long-term effects of selective decontamination on antimicrobial resistance
258. Changing bacterial ecology during a five-year period of selective intestinal decontamination
259. Randomized, controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multidisciplinary intensive care unit
260. Selective decontamination of the digestive tract helps prevent bacterial infections in the early postoperative period after liver transplant
261. Effectiveness and cost of selective decontamination of the digestive tract in critically ill intubated patients: A randomized, double-blind, placebo-controlled, multicenter trial
262. Prognostic importance of Gram-negative intestinal colonization preceding pancreatic infection in severe acute pancreatitis: Results of a controlled clinical trial of selective decontamination
263. Selective decontamination of the digestive tract: A life saver
264. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies; a consensus statement, American Thoracic Society, November 1995
265. Guidelines for prevention of nosocomial pneumonia
266. Influence of airway management on ventilator-associated pneumonia: Evidence from randomized trials
267. Prevention of nosocomial pneumonia in intubated patients: Respective role of mechanical subglottic secretions drainage and stress ulcer prophylaxis
268. Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia
269. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: The effect of body position
270. Stress ulcer prophylaxis in critically ill patients: Resolving discordant meta-analyses
271. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation: Canadian Critical Care Trials Group
272. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors
273. Continuous aspiration of subglottic secretions in preventing ventilator-associated pneumonia
274. A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients
275. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease
276. Facial mask noninvasive mechanical ventilation reduces the incidence of nosocomial pneumonia: A prospective epidemiological survey from a single ICU
277. A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure
278. Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey
279. Acute paranasal sinusitis in critically ill patients: Guidelines for prevention, diagnosis, and treatment
280. Nosocomial sinusitis with isolation of anaerobic bacteria in ICU patients
281. Nosocomial sinusitis in pediatric intensive care patients
282. The effect of nasotracheal intubation on the paranasal sinuses: A prospective study of 434 intensive care patients
283. Nosocomial sinusitis
284. Paranasal sinusitis associated with nasotracheal intubation: A frequently unrecognized and treatable source of sepsis
285. Nosocomial maxillary sinusitis during mechanical ventilation: A prospective comparison of orotracheal versus the nasotracheal route for intubation
286. Nosocomial sinusitis in ventilated patients: Nasotracheal versus orotracheal intubation
287. A randomized study assessing the systematic search for maxillary sinusitis in nasotracheally mechanically ventilated patients: Influence of nosocomial maxillary sinusitis on the occurrence of ventilator-associated pneumonia
288. Risk factors and clinical relevance of nosocomial maxillary sinusitis in the critically ill
289. Nosocomial sinusitis in patients in the medical intensive care unit: A prospective epidemiological study
290. Nosocomial sinusitis
291. Ventilator-associated sinusitis: A review
292. Maxillary sinusitis, a complication of nasotracheal intubation
293. Influence of long-term oro- or nasotracheal intubation on nosocomial maxillary sinusitis and pneumonia: Results of a prospective, randomized, clinical trial
294. Guideline for prevention of intravascular device-related infections: Hospital Infection Control Practices Advisory Committee
295. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia
296. A comparison of two antimicrobial-impregnated central venous catheters
297. Risk factors for central venous catheter-related infections in surgical and intensive care units: The Central Venous Catheter-Related Infections Study Group
298. The jury on femoral vein catheterization is still out
299. Tunneling short-term central venous catheters to prevent catheter-related infections: A meta-analysis of randomized, controlled trials
300. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: A prospective randomized multicenter study
301. Central venous catheter-related infections and their prevention: Is there enough evidence to recommend tunneling for short-term use?
302. Use of tunneled femoral catheters to prevent catheter-related infections
303. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter: A randomized, controlled trial
304. Reduced intravascular catheter infection by antibiotic bonding; a prospective, randomized, controlled trial
305. No difference in catheter sepsis between standard and antiseptic central venous catheters; a prospective randomized trial
306. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: A meta-analysis
307. Cost-effectiveness of antiseptic-impregnated central venous catheter for the prevention of catheter-related bloodstream infection
308. Central venous catheter coated with minocycline and rifampine for the prevention of catheter-related colonization and bloodstream infections: A randomized, double-blind trial
309. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukemic patients: A randomized controlled trial
310. The ex vivo antimicrobial activity and colonization of two antimicrobial-bonded central venous catheters
311. The evolving technology of venous access
312. Benefit of antiseptic and antimicrobial coating of central venous catheters: A systematic review
313. Prevention of intravascular catheter-related infections
314. Recorded criteria as a “gold standard” for sensitivity and specificity estimates of surveillance of nosocomial infection: A novel method to measure job performance
315. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion
316. Consequences of intravascular catheter sepsis
317. Education of physicians-in-training can decrease the risk for vascular catheter infection
318. Factors predisposing to bacteriuria during indwelling urethral catheterization
319. Urosepsis in the critical care unit
320. Catheter-associated urinary tract infections
321. Meatal colonization and catheter-associated bacteriuria
322. Bacteriuria in the catheterized patient: What quantitative level of bacteriuria is relevant?
323. Quantitative definition of bacteriuria
324. A prospective study of pathogenesis of catheter-associated urinary tract infections
325. Reduction of mortality associated with nosocomial urinary tract infection
326. Risk factors for nosocomial urinary tract infection
327. Urinary tract etiology of bloodstream infections in hospitalized patients
328. Extra charges and prolongation of stay attributable to nosocomial infections: A prospective interhospital comparison
329. Hospital-acquired bacteremic urinary tract infection: Epidemiology and outcome
330. Clinical and economic consequences of nosocomial catheter-related bacteriuria
331. Catheter-associated urinary tract infection is rarely symptomatic: A prospective study of 1,497 catheterized patients
332. Bacteriuria during indwelling catheter drainage: II. Effect of a closed sterile drainage system
333. Prevention of catheter-associated urinary tract infection: A cost-benefit analysis
334. The catheter and urinary tract infection
335. Preventing catheter-related bacteriuria: Should we? Can we? How?
336. Suprapubic versus transurethral catheterization of males undergoing pelvic colorectal surgery
337. Optimum method for urinary drainage in major abdominal surgery: A prospective randomized trial of suprapubic versus urethral catheterization
338. Suprapubic bladder aspiration versus urethral catheterization in ill infants: Success, efficiency and complication rates
339. Bacteriuria during urinary tract catheterization: Suprapubic versus urethral route; a prospective randomized trial
340. Prospective randomized controlled trial of urethral versus suprapubic catheterization
341. Suprapubic catheters: A comparison of suprapubic versus urethral catheters in the treatment of acute urinary retention
342. Suprapubic versus transurethral bladder drainage after colposuspension/vaginal repair
343. Acute urinary retention: Comparison of suprapubic and urethral catheterization
344. Do condom catheter collecting systems cause urinary tract infection?
345. Bladder management and urinary tract infections in Danish hospitals, nursing homes, and home care: A national prevalence study
346. External catheter use and urinary tract infections among incontinent male nursing home patients
347. Urinary incontinence in the older man
348. Antibiotic irrigation and catheter-associated urinary-tract infections
349. Does the addition of disinfectant to urine drainage bags prevent infection in catheterized patients?
350. Catheter-associated bacteriuria: Failure to reduce attack rates using periodic instillations of a disinfectant into urinary drainage systems
351. Prevention of catheter-associated urinary tract infections: Efficacy of daily meatal care regimens
352. Catheter-associated urinary tract infections: Epidemiology, pathogenesis, and prevention
353. Prophylactic ciprofloxacin for catheter-associated urinary-tract infection
354. Hydrogel/silver ion-coated urinary catheter reduces nosocomial urinary tract infection rates in intensive care unit patients: A multicenter study
355. Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: A prospective, randomized, multicenter clinical trial
356. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: A meta-analysis
357. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection
358. Catheter-associated infections in urology: Possible use of silver-impregnated catheters and the Erlanger silver catheter
359. Guideline for prevention of surgical site infection, 1999: Hospital Infection Control Practices Advisory Committee
360. Epidural versus general anesthesia, ambient operating room temperature, and patient age as predictors of inadvertent hypothermia
361. Mild perioperative hypothermia
362. Perioperative normothermia to reduce the incidence of surgical wound infection and shorten hospitalization: Study of Wound Infection and Temperature Group
363. Wound tissue oxygen tension predicts the risk of wound infection in surgical patients
364. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection
365. Antibiotic prophylaxis for cardiovascular surgery: Efficacy with coronary artery bypass
366. Preventing postoperative infections: Current treatment recommendations
367. Draft guideline for the prevention of surgical site infection, 1998: Notice
368. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection
369. Optimizing the timing of antimicrobial prophylaxis in surgery: An intervention study
370. Timeliness and use of antibiotic prophylaxis in selected inpatient surgical procedures: The Antibiotic Prophylaxis Study Group
371. Current practice of peri- and postoperative antibiotic therapy in cardiac surgery in Germany: Working Group on Cardiothoracic Surgical Intensive Care Medicine of the German Society for Thoracic and Cardiovascular Surgery
372. The potential for clinical guidelines to impact appropriate antimicrobial agent use
373. Antimicrobial prophylaxis in colorectal surgery: A systematic review of randomized controlled trials
374. Surveillance of antimicrobial prophylaxis for surgical procedures
375. Nosocomial diarrhea
376. Etiological agents of infectious diarrhea: Implications for requests for microbial culture
377. Non-Clostridium difficile nosocomial diarrhea in the intensive care unit
378. Factors associated with nosocomial diarrhea and Clostridium difficile-associated disease on the adult wards of an urban tertiary care hospital
379. Value of routine stool cultures in hospitalized patients with diarrhea
380. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients: A French multicenter study
381. Optimal methods for identifying Clostridium difficile infections
382. Clostridium difficile colitis
383. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals
384. Acquisition of Clostridium difficile and Clostridium difficile-associated diarrhea in hospitalized patients receiving tube feeding
385. A randomized crossover study of disposable thermometers for prevention of Clostridium difficile and other nosocomial infections
386. Multicenter typing comparison of sporadic and outbreak Clostridium difficile isolates from geographically diverse hospitals
387. Nosocomial enterococci resistant to vancomycin: United States, 1989-1993
388. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use
389. Hospital-wide restriction of clindamycin: Effect on the incidence of Clostridium difficile-associated diarrhea and cost
390. Guideline for infection control in healthcare personnel, 1998: Hospital Infection Control Practices Advisory Committee
391. Immunization of hospital personnel and other health care workers
392. Influenza immunization: Improving compliance of healthcare workers
393. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: A randomised controlled trial
394. Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers
395. Postexposure prophylaxis after nonoccupational HIV exposure: Clinical, ethical, and policy considerations
396. Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus